Case 2:08-cv[removed]PD Document 1 Filed[removed]Page 1 of 56 pD UNITED STATES DISTRICT COURT

First Page		Document Content
Date: 2014-10-15 10:27:07 Medicine Anorectics Psychiatry Attention-deficit hyperactivity disorder Combination drugs Adderall Lisdexamfetamine False Claims Act Shire plc Amphetamines Euphoriants Pharmacology		Case 2:08-cv[removed]PD Document 1 Filed[removed]Page 1 of 56 pD UNITED STATES DISTRICT COURT Add to Reading List Source URL: 416fizlf6ce2zuiqi2wf5x3107q.wpengine.netdna-cdn.com Download Document from Source Website File Size: 1,04 MB Share Document on Facebook

	The PROFILE®-III/VERDICT®-III products are one-step qualitative screening assays for the detection of one or more of the following: Amphetamines, Barbiturates, Benzodiazepines, Cocaine, Methamphetamine/ 3,4 Methylene DocID: 1vbZz - View Document
	The PROFILE®-III/VERDICT®-III products are one-step qualitative screening assays for the detection of one or more of the following: Amphetamines, Barbiturates, Benzodiazepines, Cocaine, Methamphetamine/ 3,4 Methylene DocID: 1uR19 - View Document
	Brit. J. Pharmacol), 24, DIFFERENTIAL EFFECTS OF TWO AMPHETAMINEBARBITURATE MIXTURES IN MAN BY D. W. DICKINS*, M. H. LADERt AND HANNAH STEINBERG DocID: 1s1P0 - View Document
	4 PHARMACOLOGIC TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS DocID: 1r9hg - View Document
	New Drugs Approved in FY 2015 Review Category Approval Date No. DocID: 1r3Vv - View Document